Coston McIsaac & Partners Boosts Stake in The Clorox Company $CLX

Coston McIsaac & Partners increased its holdings in shares of The Clorox Company (NYSE:CLX) by 17.8% during the first quarter, according to its most recent filing with the Securities & Exchange Commission. The firm owned 35,601 shares of the company’s stock after acquiring an additional 5,379 shares during the period. Coston McIsaac & Partners’ holdings in Clorox were worth $3,689,000 as of its most recent SEC filing.

Several other institutional investors and hedge funds have also recently modified their holdings of the business. Haverford Trust Co grew its holdings in Clorox by 2.8% in the fourth quarter. Haverford Trust Co now owns 3,070 shares of the company’s stock valued at $310,000 after purchasing an additional 84 shares during the period. Field & Main Bank raised its stake in shares of Clorox by 3.3% during the 4th quarter. Field & Main Bank now owns 3,100 shares of the company’s stock worth $313,000 after buying an additional 100 shares during the period. Golden State Wealth Management LLC lifted its position in shares of Clorox by 28.2% during the 4th quarter. Golden State Wealth Management LLC now owns 454 shares of the company’s stock valued at $46,000 after buying an additional 100 shares in the last quarter. Fisher Asset Management LLC lifted its position in shares of Clorox by 1.7% during the 3rd quarter. Fisher Asset Management LLC now owns 6,053 shares of the company’s stock valued at $746,000 after buying an additional 102 shares in the last quarter. Finally, Kestra Private Wealth Services LLC grew its stake in Clorox by 1.8% in the 1st quarter. Kestra Private Wealth Services LLC now owns 5,957 shares of the company’s stock valued at $617,000 after acquiring an additional 104 shares during the period. Hedge funds and other institutional investors own 78.53% of the company’s stock.

Clorox Trading Down 0.0%

Shares of CLX stock opened at $97.51 on Monday. The Clorox Company has a fifty-two week low of $84.70 and a fifty-two week high of $132.03. The company has a debt-to-equity ratio of 27.03, a quick ratio of 0.65 and a current ratio of 0.84. The stock’s fifty day moving average is $94.67 and its two-hundred day moving average is $104.45. The firm has a market capitalization of $11.79 billion, a P/E ratio of 15.83, a PEG ratio of 0.51 and a beta of 0.56.

Clorox (NYSE:CLX) last released its earnings results on Thursday, April 30th. The company reported $1.64 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $1.55 by $0.09. The business had revenue of $1.67 billion during the quarter, compared to analyst estimates of $1.67 billion. Clorox had a net margin of 11.18% and a return on equity of 443.64%. The company’s revenue for the quarter was up .1% compared to the same quarter last year. During the same quarter in the prior year, the firm earned $1.45 earnings per share. Clorox has set its FY 2026 guidance at 5.450-5.650 EPS. Research analysts expect that The Clorox Company will post 5.61 earnings per share for the current fiscal year.

Analysts Set New Price Targets

A number of research firms have weighed in on CLX. Royal Bank Of Canada reduced their price objective on shares of Clorox from $132.00 to $127.00 and set a “sector perform” rating for the company in a research report on Thursday, April 9th. The Goldman Sachs Group reiterated a “sell” rating and issued a $83.00 target price on shares of Clorox in a research report on Friday, May 1st. Zacks Research cut shares of Clorox from a “hold” rating to a “strong sell” rating in a research note on Tuesday, May 12th. BNP Paribas Exane reduced their price target on shares of Clorox from $128.00 to $97.00 and set a “neutral” rating for the company in a research report on Tuesday, May 12th. Finally, TD Cowen raised their price target on shares of Clorox from $98.00 to $111.00 and gave the company a “hold” rating in a research note on Tuesday, March 31st. One investment analyst has rated the stock with a Buy rating, eleven have issued a Hold rating and five have assigned a Sell rating to the stock. Based on data from MarketBeat.com, Clorox has a consensus rating of “Reduce” and a consensus target price of $103.40.

Insider Transactions at Clorox

In other Clorox news, Director Pierre R. Breber acquired 5,000 shares of the business’s stock in a transaction on Tuesday, May 5th. The stock was bought at an average price of $85.82 per share, for a total transaction of $429,100.00. Following the acquisition, the director owned 18,000 shares in the company, valued at approximately $1,544,760. The trade was a 38.46% increase in their ownership of the stock. The purchase was disclosed in a filing with the SEC, which is available through the SEC website. Corporate insiders own 0.63% of the company’s stock.

Clorox Company Profile

The Clorox Company is a leading manufacturer and marketer of consumer and professional products designed to help people care for their homes and live healthy, sustainable lives. Its portfolio spans cleaning and household products, food and beverages, water filtration systems and cat litter, serving both retail and institutional customers. The company’s flagship bleach and disinfecting products are well known in the United States and many international markets, where they help prevent the spread of germs in homes, hospitals, schools and businesses.

Clorox’s diverse brand lineup includes liquid bleach and surface cleaners, eco-friendly cleaning tools, food preservation and preparation items, charcoal grills and briquettes, specialty foods and beverages, pet care products and personal care lines.